Oligonucleotide Synthesis Market Research Report Information By Product (Oligonucleotide, Reagents and Equipment), By Type (Custom Oligos and Predesigned Oligos), By Applications (Therapeutic Applications, Diagnostics, Research, and Others), By End Users (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT

6.1. Overview

6.2. Oligonucleotide

6.2.1. Column-based oligos

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.2.2. Array-based oligos

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.3. Reagents

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.4. Equipment

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE

7.1. Overview

7.2. Custom Oligos

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3. Predesigned Oligos

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION

8.1. Overview

8.2. Therapeutic Applications

8.2.1. RNAi

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.2.2. Nucleic Acid Aptamers

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.2.3. DNA/Antisense Oligonucleotides

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.2.4. Immunotherapy

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.3. Diagnostics

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.4. Research

8.4.1. PCR

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.4.1. QPCR/RTQPCR

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.4.1. Sequencing

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.4.1. Gene Synthesis

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.5. Others

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030 

9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER

9.1. Overview

9.2. Hospitals

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

9.3. Specialty Clinics

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

9.4. Research Institutes

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

9.5. Diagnostic Centers

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

9.6. Others

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Oligonucleotide Synthesis Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global Oligonucleotide Synthesis Market

11.7. Key developments and Growth Strategies

11.7.1. Product Launch/Service Deployment

11.7.2. Mergers and Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix & Market Ratio

11.8.1. Sales & Operating Income 2019

11.8.2. Major Players R&D Expenditure 2019

11.9. Major Players Capital Market Ratio

12. COMPANY PROFILES

12.1. Thermo Fisher Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Overview

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Adtbio

12.2.1. Company Overview

12.2.2. Product Overview

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. Merck - Co., Inc.

12.3.1. Company Overview

12.3.2. Product Overview

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Bio-Synthesis Inc.

12.4.1. Company Overview

12.4.2. Product Overview

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Eurofins Genomics

12.5.1. Company Overview

12.5.2. Product Overview

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. GE Healthcare

12.6.1. Company Overview

12.6.2. Product Overview

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Horizon Discovery Ltd

12.7.1. Company Overview

12.7.2. Product Overview

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Agilent Technologies

12.8.1. Company Overview

12.8.2. Product Overview

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Genscript

12.9.1. Company Overview

12.9.2. Product Overview

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Kaneka Eurogentec S.A.

12.10.1. Company Overview

12.10.2. Product Overview

12.10.3. Financial Overview

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

12.11. Nitto Denko Avecia

12.11.1. Company Overview

12.11.2. Product Overview

12.11.3. Financial Overview

12.11.4. Key Developments

12.11.5. SWOT Analysis

12.11.6. Key Strategies

12.12. Integrated DNA Technologies, Inc.

12.12.1. Company Overview

12.12.2. Product Overview

12.12.3. Financial Overview

12.12.4. Key Developments

12.12.5. SWOT Analysis

12.12.6. Key Strategies

12.13. BioAutomation

12.13.1. Company Overview

12.13.2. Product Overview

12.13.3. Financial Overview

12.13.4. Key Developments

12.13.5. SWOT Analysis

12.13.6. Key Strategies

12.14. LGC Biosearch Technologies

12.14.1. Company Overview

12.14.2. Product Overview

12.14.3. Financial Overview

12.14.4. Key Developments

12.14.5. SWOT Analysis

12.14.6. Key Strategies

12.15. Others

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SYNOPSIS, 2023-2030

TABLE 2 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ESTIMATES & FORECAST, 2023-2030 (USD MILLION)

TABLE 3 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)

TABLE 4 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)

TABLE 5 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)

TABLE 6 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 7 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2023-2030 (USD MILLION)

TABLE 8 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)

TABLE 9 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)

TABLE 10 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)

TABLE 11 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 12 US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)

TABLE 13 US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)

TABLE 14 US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)

TABLE 15 US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 16 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)

TABLE 17 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)

TABLE 18 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)

TABLE 19 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 20 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)

TABLE 21 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)

TABLE 22 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)

TABLE 23 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 24 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)

TABLE 25 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)

TABLE 26 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)

TABLE 27 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 28 WESTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)

TABLE 29 WESTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)

TABLE 30 WESTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)

TABLE 31 WESTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 32 EASTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)

TABLE 33 EASTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)

TABLE 34 EASTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)

TABLE 35 EASTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 36 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)

TABLE 37 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)

TABLE 38 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)

TABLE 39 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET

FIGURE 4 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY TYPE, 2019 (%)

FIGURE 5 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY PRODUCT, 2019 (%)

FIGURE 6 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY APPLICATION, 2019 (%)

FIGURE 7 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY END USER, 2019 (%)

FIGURE 8 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY REGION, 2019 (%)

FIGURE 9 AMERICAS: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE BY REGION, 2019 (%)

FIGURE 10 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 11 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY REGION, 2019 (%)

FIGURE 12 WESTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 13 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 14 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 15 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: COMPANY SHARE ANALYSIS, 2019 (%)

FIGURE 16 THERMO FISHER SCIENTIFIC, INC.: KEY FINANCIALS

FIGURE 17 THERMO FISHER SCIENTIFIC, INC.: SEGMENTAL REVENUE

FIGURE 18 THERMO FISHER SCIENTIFIC, INC.: REGIONAL REVENUE

FIGURE 19 ADTBIO: KEY FINANCIALS

FIGURE 20 ADTBIOV: SEGMENTAL REVENUE

FIGURE 21 ADTBIO: REGIONAL REVENUE

FIGURE 22 MERCK - CO., INC.: KEY FINANCIALS

FIGURE 23 MERCK - CO., INC.: SEGMENTAL REVENUE

FIGURE 24 MERCK - CO., INC.: REGIONAL REVENUE

FIGURE 25 BIO-SYNTHESIS INC.: KEY FINANCIALS

FIGURE 26 BIO-SYNTHESIS INC.: SEGMENTAL REVENUE

FIGURE 27 BIO-SYNTHESIS INC.: REGIONAL REVENUE

FIGURE 28 EUROFINS GENOMICS: KEY FINANCIALS

FIGURE 29 EUROFINS GENOMICS: SEGMENTAL REVENUE

FIGURE 30 EUROFINS GENOMICS: REGIONAL REVENUE

FIGURE 31 GE HEALTHCARE: KEY FINANCIALS

FIGURE 32 GE HEALTHCARE: SEGMENTAL REVENUE

FIGURE 33 GE HEALTHCARE: REGIONAL REVENUE

FIGURE 34 HORIZON DISCOVERY LTD: KEY FINANCIALS

FIGURE 35 HORIZON DISCOVERY LTD: SEGMENTAL REVENUE

FIGURE 36 HORIZON DISCOVERY LTD.: REGIONAL REVENUE

FIGURE 37 AGILENT TECHNOLOGIES: KEY FINANCIALS

FIGURE 38 AGILENT TECHNOLOGIES: SEGMENTAL REVENUE

FIGURE 39 AGILENT TECHNOLOGIES: REGIONAL REVENUE

FIGURE 40 GENSCRIPT: KEY FINANCIALS

FIGURE 41 GENSCRIPT: SEGMENTAL REVENUE

FIGURE 42 GENSCRIPT: REGIONAL REVENUE

FIGURE 43 KANEKA EUROGENTEC SA: KEY FINANCIALS

FIGURE 44 KANEKA EUROGENTEC SA: SEGMENTAL REVENUE

FIGURE 45 KANEKA EUROGENTEC SA: REGIONAL REVENUE

FIGURE 46 NITTO DENKO AVECIA: KEY FINANCIALS

FIGURE 47 NITTO DENKO AVECIA: SEGMENTAL REVENUE

FIGURE 48 NITTO DENKO AVECIA: REGIONAL REVENUE

FIGURE 49 INTEGRATED DNA TECHNOLOGIES, INC.: KEY FINANCIALS

FIGURE 50 INTEGRATED DNA TECHNOLOGIES, INC.: SEGMENTAL REVENUE

FIGURE 51 INTEGRATED DNA TECHNOLOGIES, INC.REGIONAL REVENUE

FIGURE 52 BIOAUTOMATION: KEY FINANCIALS

FIGURE 53 BIOAUTOMATION: SEGMENTAL REVENUE

FIGURE 54 BIOAUTOMATION: REGIONAL REVENUE

FIGURE 55 LGC BIOSEARCH TECHNOLOGIES:.KEY FINANCIALS

FIGURE 56 LGC BIOSEARCH TECHNOLOGIES.: SEGMENTAL REVENUE

FIGURE 57 LGC BIOSEARCH TECHNOLOGIES.: REGIONAL REVENUE

FIGURE 58 SAREPTA THERAPEUTICS:KEY FINANCIALS

FIGURE 59 SAREPTA THERAPEUTICS: SEGMENTAL REVENUE

FIGURE 60 SAREPTA THERAPEUTICS: REGIONAL REVENUE

FIGURE 61 AGILENT TECHNOLOGIES:KEY FINANCIALS

FIGURE 62 AGILENT TECHNOLOGIES: SEGMENTAL REVENUE

FIGURE 63 AGILENT TECHNOLOGIES: REGIONAL REVENUE